Hany M Abd El-Lateef, Lashin S Ali, Safa H Qahl, Dalal N Binjawhar, Eman Fayad, Maha A Alghamdi, Sarah A Altalhi, Fawziah A Al-Salmi, El Shaimaa Shabana, Kholoud H Radwan, Ibrahim Youssef, Saad Shaaban, Hanan M Rashwan, Shady G El-Sawah
Type 1 diabetes stem-cell-based treatment approach is among the leading therapeutic strategies for treating cardiac damage owing to the stem cells' regeneration capabilities. Mesenchymal stem cells derived from adipose tissue (AD-MSCs) have shown great potential in treating diabetic cardiomyopathy (DCM). Herein, we explored the antioxidant-supporting role of N, N'-diphenyl-1,4-phenylenediamine (DPPD) in enhancing the MSCs' therapeutic role in alleviating DCM complications in heart tissues of type 1 diabetic rats...
April 9, 2024: Journal of Experimental Zoology. Part A, Ecological and Integrative Physiology